Us Bancorp \De\ Alkermes Plc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Alkermes Plc. stock. As of the latest transaction made, Us Bancorp \De\ holds 10,302 shares of ALKS stock, worth $296,491. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,302

Previous 6,924 48.79%

Holding current value

$296,491

Previous $166,000 73.49%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$23.01 - $28.55 $77,727 - $96,441	3,378 Added 48.79%	10,302 $288,000
Q2 2024 Aug 06, 2024	SELL	$23.21 - $27.24 $464 - $544	-20 Reduced 0.29%	6,924 $166,000
Q1 2024 May 07, 2024	SELL	$26.4 - $32.56 $53,961 - $66,552	-2,044 Reduced 22.74%	6,944 $187,000
Q4 2023 Feb 09, 2024	BUY	$23.37 - $28.68 $3,856 - $4,732	165 Added 1.87%	8,988 $249,000
Q3 2023 Nov 03, 2023	BUY	$27.17 - $31.97 $147,668 - $173,756	5,435 Added 160.42%	8,823 $247,000
Q2 2023 Aug 09, 2023	SELL	$28.34 - $33.63 $6,744 - $8,003	-238 Reduced 6.56%	3,388 $106,000
Q1 2023 May 09, 2023	SELL	$25.31 - $29.02 $36,724 - $42,108	-1,451 Reduced 28.58%	3,626 $102,000
Q4 2022 Feb 13, 2023	SELL	$21.94 - $26.24 $18,385 - $21,989	-838 Reduced 14.17%	5,077 $132,000
Q3 2022 Oct 27, 2022	SELL	$22.0 - $31.87 $59,906 - $86,782	-2,723 Reduced 31.52%	5,915 $133,000
Q2 2022 Aug 01, 2022	SELL	$26.4 - $30.54 $51,031 - $59,033	-1,933 Reduced 18.29%	8,638 $258,000
Q1 2022 May 11, 2022	BUY	$23.07 - $27.99 $47,155 - $57,211	2,044 Added 23.97%	10,571 $279,000
Q4 2021 Feb 11, 2022	BUY	$21.47 - $32.08 $92,900 - $138,810	4,327 Added 103.02%	8,527 $198,000
Q2 2021 Aug 05, 2021	SELL	$18.78 - $25.15 $1,464 - $1,961	-78 Reduced 1.82%	4,200 $103,000
Q1 2021 Apr 28, 2021	BUY	$18.21 - $23.2 $11,982 - $15,265	658 Added 18.18%	4,278 $80,000
Q4 2020 Feb 04, 2021	BUY	$15.39 - $22.1 $28,640 - $41,128	1,861 Added 105.8%	3,620 $72,000
Q3 2020 Nov 10, 2020	BUY	$16.16 - $20.66 $9,324 - $11,920	577 Added 48.82%	1,759 $29,000
Q2 2020 Aug 07, 2020	BUY	$13.31 - $19.41 $9,463 - $13,800	711 Added 150.96%	1,182 $23,000
Q1 2020 May 13, 2020	BUY	$13.06 - $21.24 $4,348 - $7,072	333 Added 241.3%	471 $7,000
Q4 2019 Feb 04, 2020	SELL	$17.29 - $21.74 $2,576 - $3,239	-149 Reduced 51.92%	138 $3,000
Q3 2019 Nov 08, 2019	BUY	$19.51 - $24.28 $897 - $1,116	46 Added 19.09%	287 $6,000
Q2 2019 Aug 13, 2019	SELL	$21.47 - $37.33 $4,701 - $8,175	-219 Reduced 47.61%	241 $6,000
Q1 2019 May 08, 2019	BUY	$28.4 - $36.49 $1,789 - $2,298	63 Added 15.87%	460 $17,000
Q4 2018 Feb 13, 2019	SELL	$27.94 - $44.61 $48,811 - $77,933	-1,747 Reduced 81.48%	397 $12,000
Q3 2018 Nov 01, 2018	SELL	$38.6 - $46.12 $6,291 - $7,517	-163 Reduced 7.07%	2,144 $92,000
Q2 2018 Aug 08, 2018	SELL	$40.56 - $51.36 $85,946 - $108,831	-2,119 Reduced 47.88%	2,307 $95,000
Q1 2018 May 08, 2018	BUY	$53.61 - $67.26 $8,523 - $10,694	159 Added 3.73%	4,426 $256,000
Q4 2017 Feb 02, 2018	BUY	$47.69 - $55.39 $15,737 - $18,278	330 Added 8.38%	4,267 $233,000
Q3 2017 Nov 13, 2017	BUY	$49.16 - $54.45 $193,542 - $214,369	3,937	3,937 $200,000

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account